summit study tirzepatide hfpef trial In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in trial https://t.co/8ZHm4gySiL Real-world efficacy of tirzepatide in
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23







32260-8/asset/49a02715-866b-43be-818a-fd87392a76a5/main.assets/gr2_lrg.jpg)





















